{
  "id": 4025209,
  "title": "Nonobstructive Heart Enlargement Responds to Aficamten",
  "url": "https://urgent.news/2026/08/28/nonobstructive-heart-enlargement-responds-to-aficamten",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-28T19:15:16.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/esc/122812"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Treatment with aficamten (Myqorzo) improved exercise capacity as well as health status and symptoms in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM) in a large, double-blind, placebo-controlled trial...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}